18.9.2018
Hisashi Akiyama, Boston
Innate immune activation in HIV infection

3.7.2018
John Doorbar, Cambridge

29.5.2018
Vincent Parissi, Bordeaux

24.4.2018
Harald Wodrich, Bordeaux
In vivo labeling of adenovirus DNA identifies Chromatin anchoring and biphasic Genome replication

26.3.2018
Jan Münch, Ulm
Exploiting the human peptidome for novel antiviral and anticancer agents

13.3.2018
Bryan Cullen, Duke University
Viral epitranscriptomics

6.2.2018
Florian Greten
Inflammatory signalling in early and late stages of tumorigenesis

30.1.2018
Kashif Sadiq, Heidelberg
Modelling Protease-triggered activation of HIV-1

7.11.2017
Denise Galloway
Preventive and therapeutic approaches for DNA Tumor viruses

17.10.2017
Peter Sarnow
Role of miRNA122 and circular RNA in the HCV life cycle

10.10.2017
Dahai Luo
Biogenesis and detection of flaviviral RNA

9.10.2017
Eric O Freed, Frederick
HIV-1 assembly and maturation

19.9.2017
Eelco van Anken
ER stress and homeostasis

5.9.2017
Nicolas Locker
Unraveling the multifacted regulation of mRNA life by norovirus

18.7.2017
Stefan Wieland

20.6.2017
Alexander Ploss
New insights into the biology of HEV and HDV host tropism

25.4.2017
Andrew Griffiths, Paris
High-throughput single cell Analysis

20.4.2017
Roberto Cattaneo
Insights into measles virus biology

18.4.2017
Adolfo Garcia-Sastre, New York
Influenza virus host interactions

11.4.2017
Melanie Ott, San Francisco
Epigenetic control of HIV latency

14.3.2017
Antonio Bertoletti
Engineering T-cells for the therapy of chronic HBV infection

28.2.2017
Yves Gaudin, Gif-sur-Yvette
Rabies virus replication factories are membrane-less organelles

12.12.2016
Peter Nagy, Lexington
Assembly of tombovirus replicase

6.12.2016
Luka Cicin-Sain, Braunschweig
Strategies for optimizing anti-tumoral CMV based vectors.

2.12.2016
Petr Chlanda, Bethesda
Influenza Virus hemagglutinin: to fuse or to break trying

8.11.2016
Alexander Hoffmann, Los Angeles
Dynamics and noise of NFkappaB signalling

25.10.2016
Melanie Brinkmann, Braunschweig
Evasion of type I IFN Response by CMV

18.10.2016
Terry Dermody, Pittsburgh
A neural targeting receptor for reovirus

11.10.2016
Hal Drakesmith, Oxford
The role of iron and hepcidin in global health and antiviral immunity

4.10.2016
Michael Weekes, Cambridge
Insights into CMV immune evasion from quantitative multiplexed proteomics

27.9.2016
Gunnar Schotta, Munich
Chromatin based restriction of endogenous retroviruses

15.9.2016
Wesley Sundquist, Salt Lake City
Mechanistic studies of the ESCRT pathway

6.9.2016
Adam Grundhoff, Hamburg

29.7.2016
Tim Lämmermann, Freiburg
Innate immune cell Dynamics at sites of inflammation and infection

12.7.2016
John Ziehbuhr
Nidovirales: special enzymes for very special viruses

5.7.2016
Julie Pfeiffer
How gut microbes enhance virus infectivity

29.6.2016
Charles M. Rice
HCV and beyond

21.6.2016
Christian Drosten, Bonn
Coronavirus evolution

31.5.2016
Hendrik Streeck, Essen
T follicular helper cells in chronic HIV-1 infection

19.4.2016
Martin Schwemmle
Reverse genetics of bat influenza viruses

22.3.2016
Musa Mhlanga, Pretoria
A tale of two lncRNAs in infection and immunity

15.3.2016
Ian Goodfellow, Cambridge
Control of innate immune response in  Norovirus infection

24.2.2016
Eric O. Freed, NCI Frederick
HIV-1 assembly and maturation

26.1. 2016
Torsten Schaller, Heidelberg
TypeI IFN induced post-entry blocks to HIV-1

15.12.2015
Stephan Becker, Marburg
Replication and Assembly of filoviruses

17.11.2015
Jens Bukh
Adaptation and neutralization studies of HCV

27.10.2015
Walther Mothes, Yale University
Visualizing individual steps in the retroviral life cycle in living animals and at the single molecule Level

29.9.2015
Massimo Pizzato, Trento
SERINC5, a transmembrane Inhibitor ofg retroviral replication

26.5.2015
Anna Cereseto, Trento
3D analysis of retrovirus nuclear interactions

12.5.2015
Friedemann Weber
Induction and Suppression of IFN Response by RNA viruses

14.4.2015
Misha Kozlov, Tel Aviv
A model for ER morphologies

7.4.2015
Robert Garcea, Boulder
Virus assembly factories in polyoma virus infected cells

27.1.2015
Greg Towers, London
HIV versus intracellular innate immunity

13.1.2015
Alexander Khromykh, Brisbane
Viral factors determining the outcome of West Nile Virus infection

16.12.2014
Christiane Wobus, Ann Arbor
What murine norovirus teaches us about norovirus biology 

25.10.2014
Stuart Neil, London
The Ys and wherefores of tetherin's action and HIV-1 counteraction

7.10.2014
Gerald Hammond
The complex role of inositol lipids in cell biology

30.9.2014 Kay Grünewald, Oxford

23.9.2014
Andrew Mouland
HIV-1 induced disassembly of stress granules

22.7.2014
Baek Kim, Atlanta
Restricting HIV-1 reverse transcription kinetics by SAMHD1

15.7.2014
Mario Schelhaas
Human papillomavirus entry into host cells

29.4.2014
Leo James, Cambridge

25.3.2014
Marina Lusic, Trieste
Regulation of HIV-1 integration site selection through chromatin structure

14.1.2014
Paul Walther, Ulm
3D imaging of high-pressure frozen cells with SEM

19.11.2013
Stanley Lemon
Membrane hijacking and the pathogenesis of Hepatitis A

12.11.2013
Ulf Dittmer, Essen
The role of Tregs in retroviral infections

15.10.2013
Michael Diamond
Immune evasion and host control of alphavirus and flavivirus infection

16.7.2013
Ali Amara, Paris
Dengue viruses expolit TIM and TAM for virus entry

2.7.2013
Itay Rousso, Beer Sheva
Physical properties of retroviruses

11.6.2013
Thomas Peters, Lübeck
Insights into virus infections from NMR

28.5.2013
Matthias Hornef, Hannover
The intestinal epithelium in host-microbial interaction

30.4.2013
Renate König, Langen
Restriction of HIV-1 replication in myeloid cells

16.4.2013
Ari Helenius, Zürich
Five pathways of virus entry

11.12.2012
Bryan Cullen, Duke University
Viruses and miRNAs

4.12.2012
John Schoggins, Dallas
Antiviral IFN effectors

20.11.2012
Javier Martinez-Picado, Barcelona
Rapid HIV-1 disease progression

13.11.2012
Roberto Cattaneo, Mayo Clinic
New receptors for old viruses

6.11.2012
Jan Rehwinkel
How RIG-I and SAMHD1 protect against viruses

30.10.2012
Roberto Speck, Zürich
Humanized Mice for studying HIV

23.10.2012
Chae-Ok Jun
Smart nanoconjugate platforms for administration of adenoviruses

17.7.2012
Eva Harris, Berkeley
Natural and therapeutic antibodies and B-cell response against Dengue virus

26.6.2012
Steeve Boulant, Heidelberg
From virus entry to innate immune sensing

17.4.2012
Andrew Bowie
Activation and evasion of host pattern recognition receptor signalling by viruses

10.4.2012
Michael Hoelscher, München
From bedside to bench: how clinical studies can inspire basic research

28.2.2012
Nicolas Manel, Paris
Innate sensing of HIV by dendritic cells

21.2.2012
Raffaele DiFrancesco, Milan
Interaction of HCV with host cell lipids

31.1.2012
Andrew Lever, Cambridge
HIV RNA packaging and assembly

17.1.2012
Richard Kuhn, West Lafayette
Assembly and replication of Dengue virus

13.12.2011
Amalio Telenti, Lausanne
HIV restriction factors

18.10.2011
Brett Lindenbach, New Haven
genetics, biochemistry and imaging of HCV assembly

27.9.2011
Matthias Fischer, Heidelberg
The puzzling evolution of giant DNA viruses

21.6.2011
Hansjörg Hauser, Braunschweig
Dynamics of IFN signalling

03.05.2011
Michael Kozlov, Tel Aviv
Modeling membrane shaping by proteins

19.4.2011
Richard Vile, Rochester
Oncolytic virotherapy and tumor immunology

12.4.2011
Robert Thimme, Freiburg
Adaptive immune responses to HIV infections

29.3.2011
Marc Sitbon, Marseille
Retroviral receptors and nutrient transporters

15.3.2011 Andrew Davidson, Bristol

Dengue virus pathogenesis

1.3.2011
Philip Stevenson, Cambridge
Tracking herpesvirus entry

26.2.2011
Adam Grundhoff, Hamburg
Epigenetic determinants of KSHV latency

15.2.2011
Pablo Gastaminza, Madrid
HCV infection in tissue culture

1.2.2011
Thomas Baumert, Strasbourg
HCV and hepatocellular carcinoma

26.1.2011
Zeger Debyser, Leuven
Cellular cofactors of HIV integrase

16.12.2010
Stefan Taube, Ann Arbor
The role of glycans in Norovirus entry

14.12.2010
Eliane Meurs
HCV and the control of IFN induction

30.11.2010
Veit Hornung, Bonn
Inflammasomes: IL-1 mediated inflammation and beyond

16.11.2010
Mark Harris, Leeds
Dysregulation of cellular metabolic pathways by HCV

3.11.2010
George Banting, Bristol
Links between tetherin, the actin cytoskeleton and lipd rafts (with a mention of Vpu)

26.10.2010
Alessandro Marcello, Trieste
Virus replication dynamics: Insights from HIV and flaviviruses

21.9.2010
Volker Thiel
Coronaviruses - more than SARS

20.9.2010
Eckhardt Wimmer, Stony Brook

20.7.2010
Jane McKeating, Birmingham
The complexities of HCV entry

13.7.2010
Christian Eggeling, Göttingen
Nanoscale membrane dynamics revealed by far-field STED fluorescence microscopy

29.06.2010
Cristina Risco, Madrid
Studying virus factories and cell architecture with new high resolution imaging techniques

15.06.2010
Klemens Rottner, Braunschweig
Dissection of cortactin function in cell motility and host-pathogen interaction

29.03.2010
Felix Rey, Paris:
Structural organisation of the Chikungunya virus
surface glycoprotein shell: allosteric activation
for entry upon interactions with receptor

16.3.2010
Otto Haller, Freiburg
Innate immunity to influenza viruses

26.1.2010
Beate Sodeik, Hannover
Herpes simplex virus: a hitch hiker's guide trough the cell

19.1.2010
Detlev Krüger, Berlin:
Evolution and molecular virology of Dobravavirus

12.1.2010
Andreas Pichelmair, Vienna:
Exploiting viral know how to study antiviral immunity

15.12.2009
Jolanda Smit, Groningen
Early events in flavivirus replication

24.11.2009
David Teis, Innsbruck:
The regulated assembly of ESCRT-III machinery controls MVB vesicle formation

3.11.2009
Michaela Gack, Southborough
RIG-I- and TRIM25-mediated antiviral innate immunity and viral evasion of Influenza virus

27.10.2009
Fabian Leendertz, Berlin
Zoonotic Potential of Pathogens from Tropical Rainforests

6.10.2009
Peter Tattersall, New Haven
Role of capsid structure and dynamics in the parvovirus life cycle

8.9.2009
Bryan Cullen, Durham
Viruses and miRNAs

30.6.2009
Christof von Kalle, Heidelberg
Genetic modification of blood forming stem cells with viral and synthetic vectors

26.5.2009
Clare Jolly, London
HIV-1 cell transmission

19.5.2009
Peter Aichele
Direct impact of type I interferons and IL-12 on CD8 cells in the context of viral and bacterial infections

21.04.2009
Luis Enjuanes, Madrid
Gene expression and protection in coronaviruses

7.4.2009
Charles Bangham, London
How does HTLV-1 persist in vivo?

31.3.2009
Markus Thali, Burlington
Tetraspanin functions in HIV replication

24.2.2009
Teunis Geijtenbek, Amsterdam
Dendritic subsets in HIV infection

17.02.2009
Glen Randall, Chicago
Illuminating HCV replication

27.01.2009
Ludger Johannes, Paris

20.01.2009
Greg Towers, London
Catch me if you can - innate restriction of viral infection

16.12.2008
Bruno Carnard, Marseille
Structural and functional studies of flavivirus replicases and their use for drug design

18.11.2008
Volker Haucke, Berlin
Regulation of adapter-mediated endosomal membrane dynamics

28.10.2008
Thomas Lengauer, Saarbrücken
Chasing the virus: computer help for treating AIDS patients

21.10.2008
Camille Sureau, Paris
Viral entry determinants of the HBV envelope proteins

2.10.2008
Mike Summers, HHMI, Baltimore
NMR studies of retroviral genome packaging and assembly

24.7.2008
Beatrice Hahn, University of Alabama
Tracing AIDS to its zoonotic routes.

8.7.2008
Heinrich Leonhardt, München
Visualization and Manipulation of the Invisible with Tools from the Desert and a bad Illumination<//span>

17.6.2008
Andrew Bowie, Dublin
Learning from viruses about host immune signalling pathways

10.6.2008
Adolfo Garcia-Sastre, New York
Induction and inhibition of the type I interferon response by RNA viruses

27.05.2008 Frank Buchholz, Dresden

20.05.2008
Tero Ahola, Helsinki
Structure and function of the membraneous replication complex of alphaviruses

05.05.2008
Ramon Alemany, Barcelona

29.04.2008 Santos Manes, Madrid

15.04.2008
Thilo Stehle, Tübingen
How do viruses engage their receptors?

25.03.2008
Jürgen Haas, Edinburgh
Systems Virology

26.02.2008
Kay Grünewald, München
Approaching cell biology of virus infection by cryo-electron tomography 

19.02.2008
Georg Kochs, Freiburg
Factors leading to high virulence of an exceptional mouse-adapted human influenza A virus   

29.01.2008
Klaus Überla, Bochum
Role of the lentiviral Rev protein in genomic RNA packaging and novel immunization strategies against HIV

18.12.2007
Michael Nassal
Chaperone-dependent protein-primed reverse transcription by hepatitis B viruses  

11.12.2007
Mario Schelhaas, Zürich:
Probing the entry of the small DNA viruses, SV40 and HPV16:From cell surface motion to uncoating

27.11.2007
Hartmut Hengel, Düsseldorf
Cytomegalovirus evasion from innate and adaptive immune responses 

30.10.2007
Alexandra Trkola, Zürich
'HIV immunization - neutralization and beyond'

25.09.2007
Johnson Mak, Melbourne
'HIV assembly - from a probe of lipid membrane biology to manipulating the evolution of HIV-1' 

25.04.2007
Jonathan Yewdell, Bethesda
Generating MHC classI ligands from DRiPs

24.04.2007
Urs Greber, Zürich
Time resolved imaging of viral infection processes

27.03.2007
Ulrike Protzer, Köln
How cytokines and T-cells control hepatitis B virus

27.02.2007
Ben Berkhout, Amsterdam
Towards an RNAi gene therapy of HIV-1

30.01.2007
Steve Fuller, Oxford
Electron microscopy reveals how HIV cheats during assembly and infection

28.11.2006
Dirk Lindemann, Dresden
Foamy virus egress

31.10.2006
uan Martin-Serrano, London
The role of cellular proteins in enveloped virus budding and endosomal sorting

18.07.2006
Jonathan Stoye, London
A collection of retroviral restriction factors

30.05.2006
Nicole Fischer, Hamburg
Identification of a novel gammaretrovirus in prostate tumors homozygous for a RANSL variant using DNA microarrays

25.4.2006
Thomas Menees, Kansas City
Host factors and retroviral RNA dynamics

21.03.2006
Hans-Dieter Klenk, Marburg
Interspeziestransmission und Wirtsadaption bei Influenzaviren

14.02.2006
Charles Bangham, Londonv How does HTLV-I persist?

31.01.2006
Jeremy Luban, New York
TRIM5, Cyclophilin A and Innate Resistance to HIV-1

17.11.2005
Peter Palese, New York
Reconstruction and characterization of the extinct 1918 Influenza virus

25.10.2005
Christopher Baum, Hannover
Retroviral transgenesis and oncogenesis

27.09.2005
Simon Wain-Hobson, Paris
Genetic editing of retroviruses to death

19.07.2005
Winfried Weissenhorn, Grenoble
Structures of cellular factors implicated in multivesicular body formation and enveloped virus budding

05.07.2005
Francois-Loic Cosset, Lyon
Retrovirus pseudotyping: assembly mechanisms, engineering and properties Birke Bartosch, Lyon4717 Infectious HCV pseudo-particles: New insights into HCV cell-entry and neutralisation 

26.04.2005
Quentin Sattentau, Oxford
T-cell complicity in HIV spread

12.04.2005
Bryan Cullen, Durham
Expression and function of human microRNAs

29.03.2005
Michael Malim, London
Natural resistance to HIV infection: the Vif-APOBEC interaction

22.02.2005
Axel Rethwilm, Würzburg
Molecular Biology of Foamy viruses

18.01.2005
Maik Lehmann, New Haven
Actin- and myosin-driven surfing of viruses along filopodia precedes their entry into cells

30.11.2004
Egbert Flory, Langen
Mitogenic signaling pathways involved in lentivirus-induced acute lethal enteropathy

26.10.2004
Olivier Schwartz, Paris
HIV, dendritic cells and lymphocytes: virological and immunological interactions

01.10.2004
Eric Freed, Frederick
Novel insights into HIV assembly and maturation

30.09.2004
Wes Sundquist, Salt Lake City
Biochemistry of HIV budding

28.09.2004
Albert Osterhaus, Rotterdam
Emerging virus infections in a changing world

06.07.2004
Jitka Forstova, Prague
Mouse polyomavirus: Interactions of virions with host cell structures

01.06.2004
Stefan Pöhlmann, Erlangen
Functional analysis of the S protein of the SARS coronavirus

27.04.2004
Franz Heinz, Vienna
The tick-borne encephalitis virus model of flavivirus envelope glycoprotein structure and function

23.03.2004
Felix Rey, Gif-sur-Yvette
Crystal Structures of the low-pH triggered membrane-fusion form of the alpha- and flavivirus envelope proteins

24.02.2004
Mark Marsh, London
Intracellular assembly of HIV

04.02.2004
John Briggs, Hertford College, Oxford
Determining the quantity of Gag in the HIV virion

27.01.2004
Carsten Münk, Paul-Ehrlich-Institut, Langen
Post-entry restrictions of HIV-1 in simian cells

25.11.2003
Ari Helenius, Zurich
Pathways of virus entry into animal cells

18.10.2003
Christian Drosten, Hamburg
SARS

14.10.2003
Eckard Wimmer, Stony Brook
Replication and pathogenesis of a chemical called poliovirus

30.09.2003
Urs Greber, Zürich
Adenovirus entry

22.07.2003
Ulrich Koszinowski, München
Genome wide and gene specific approaches to cytomegalovirus functions

21.07.2003
Nat Landau, La Jolla
Restrictions to HIV replication in small animal models

14.07.2003
Art Alberts, Grand Rapids
Formin dynamics in cytoskeletal remodeling

17.06.2003
Harald Wodrich, La Jolla
Nuclear transport in adenoviral replication: Functional roles for proteins VI and VII

20.05.2003
Stephan Becker, Marburg
VP40, the matrix protein of filoviruses: molecular characterization and intracellular transport

29.04.2003
Wolfgang Hammerschmidt, München
Molecular functions of latent genes in Epstein-Barr virus-infected human B cells